In this article, we will list the 5 Best Cheap Stocks Under $10 to Buy in June. Please visit 10 Best Cheap Stocks Under $10 to Buy in June to see the extended list and the methodology behind it.
5. Kosmos Energy Ltd. (NYSE:KOS)
Number of Hedge Fund Holders: 43
Kosmos Energy Ltd. (NYSE:KOS) is one of the best cheap stocks under $10 to buy in June. On May 5, Kosmos Energy achieved record production in Q1 2026, averaging 74,800 barrels of oil equivalent per day, a 25% increase year-over-year. Despite this operational milestone, the company reported a net loss of $226 million, or an adjusted net loss of $36 million. Revenue for the period totaled $371 million, while production expenses were reduced by approximately 22% compared to the same quarter in 2025.
The company is executing on its strategic goals to lower costs and reduce debt, completing a $350 million bond offering and a $200 million equity raise. Consequently, management has increased the full-year debt reduction target from 10% to approximately 20%. Other major developments include the sale of assets in Equatorial Guinea, the final investment decision for the Tiberius project in the Gulf of America, and a new strategic exploration alliance with Shell.
Kosmos Energy Ltd. (NYSE:KOS) now maintains its full-year 2026 CapEx guidance of $350 million. With production ramp-ups at the Greater Tortue Ahmeyim project and new wells coming online at Jubilee, the company expects to capitalize on premium international oil markets. Leadership continues to prioritize balance sheet strength by directing excess free cash flow toward further debt repayment.
Kosmos Energy Ltd. (NYSE:KOS) is an independent oil and gas company that focuses on offshore exploration, development, and production. Its core assets are in Ghana, Mauritania/Senegal LNG, Equatorial Guinea, and the US Gulf of Mexico.
4. BellRing Brands Inc. (NYSE:BRBR)
Number of Hedge Fund Holders: 45
BellRing Brands Inc. (NYSE:BRBR) is one of the best cheap stocks under $10 to buy in June. On May 5, BellRing Brands reported FQ2 2026 net sales of $598.7 million, a modest 2% year-over-year increase driven by volume growth. Despite this, the company faced significant margin pressure, resulting in an operating profit of $66 million and net earnings of $33.9 million. These figures were impacted by higher freight costs, significant input cost inflation, and an $11.3 million inventory-related charge.
Performance across brands was mixed, with Premier Protein sales rising 1.7% due to increased promotional activity and distribution gains, while Dymatize sales fell 1.9% as volume declines were only partially offset by higher average selling prices. CEO Darcy Davenport noted that heightened consumer price sensitivity and a competitive promotional environment created a challenging quarter, though she emphasized that the company’s core brand metrics, such as household penetration, remain strong.
BellRing Brands Inc. (NYSE:BRBR) now expects net sales to range between $2.325 billion and $2.365 billion, with Adjusted EBITDA projected between $315 million and $335 million for the full FY26. Management plans to continue investing in advertising and supporting long-term growth while taking strategic actions to improve financial performance through the remainder of the year.
BellRing Brands Inc. (NYSE:BRBR) distributes ready-to-drink protein shakes, ready-to-mix powders, and nutrition bars across multiple channels such as warehouse clubs, drugstores, e-Commerce, specialty stores, and convenience stores. The company is located in St. Louis, Missouri and was founded on March 2019.
3. ADMA Biologics Inc. (NASDAQ:ADMA)
Number of Hedge Fund Holders: 46
ADMA Biologics Inc. (NASDAQ:ADMA) is one of the best cheap stocks under $10 to buy in June. On May 4, ADMA Biologics received FDA approval to expand the label for its specialty biologic, ASCENIV, to include pediatric patients aged two years and older. Previously, the treatment was restricted to primary humoral immunodeficiency/PI patients aged 12 and older. This approval follows the completion of a required post-marketing pediatric assessment and marks a significant expansion of the therapy’s reach.
CEO Adam Grossman stated that the expanded indication allows the company to address the needs of younger immune-compromised patients much earlier in their treatment journey. The clinical milestone highlights the success of the company’s pediatric assessment program, which was driven by collaborative efforts between ADMA’s operational teams, medical professionals, and participating families.
ASCENIV is a plasma-derived, polyclonal intravenous immune globulin manufactured using ADMA Biologics Inc.’s (NASDAQ:ADMA) proprietary donor screening and plasma pooling methodology. Protected by a portfolio of international patents, the product is designed to provide polyclonal antibodies that help the immune system neutralize bacteria and viruses. The company plans to prioritize the continued utilization of this treatment as a key option for pediatric care.
ADMA Biologics Inc. (NASDAQ:ADMA) is a biopharmaceutical company that manufactures, markets, and develops speciality plasma-derived biologics. It conducts operations through the following business segments: ADMA BioManufacturing and Plasma Collection Center.
2. Avantor Inc. (NYSE:AVTR)
Number of Hedge Fund Holders: 46
Avantor Inc. (NYSE:AVTR) is one of the best cheap stocks under $10 to buy in June. On April 23, Avantor announced the appointment of Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products/BMP and Chief Transformation Officer, effective May 1. In this dual role, Brellier will oversee the growth and operational performance of the BMP business while leading the company’s enterprise-wide transformation initiative, the Revival Management Office.
Brellier joins the company from Danaher, where he most recently served as President of Cytiva’s Hardware Solutions business. His previous experience includes significant leadership roles in biopharma innovation, manufacturing, and commercialization, as well as managing the integration of Pall Life Sciences into Cytiva. Avantor’s leadership noted that his background in business transformation will be essential as the company executes its broader strategic initiatives.
Benoit Gourdier, the current Executive Vice President of the BMP segment, will remain with Avantor until the end of 2026 to facilitate an orderly leadership transition. Avantor’s President and CEO, Emmanuel Ligner, expressed confidence that Brellier’s operational expertise will help maximize the potential of the company’s product brands and support long-term sustainable growth.
Avantor Inc. (NYSE:AVTR) is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. It serves as an important partner in research, development, and production in the medicine, healthcare, and technology markets.
1. Fermi Inc. (NASDAQ:FRMI)
Number of Hedge Fund Holders: 51
Fermi Inc. (NASDAQ:FRMI) is one of the best cheap stocks under $10 to buy in June. On May 14, Fermi unveiled “Fermi 2.0,” a shift designed to transition the company into a scaled, institutional provider of gigawatt-scale power for the AI industry. With over $1.4 billion in infrastructure already established, the company is focusing its next 90 days on finalizing binding tenant agreements, managing liquidity, and appointing a new CEO to lead the commercialization of its Project Matador campus.
Operational progress at the 7,500-acre site in Texas remains on schedule, with the company securing more than 2 GW of power generation capacity and advancing approximately 11 GW of permitted capacity. Notable milestones include receiving a 6 GW Clean Air Permit from the TCEQ (the second-largest of its kind in the US) and gaining participation in an NRC pilot program to expedite nuclear licensing. Additionally, the first six Siemens gas turbines have arrived, and core site infrastructure is nearing completion.
Commercial interest is accelerating, with active discussions underway with major hyperscalers and enterprise compute operators. Leadership remains confident that the project’s unique combination of secured land, permitting progress, and equipment availability positions it to serve as a critical infrastructure partner for high-demand AI tenants. Fermi Inc. (NASDAQ:FRMI) plans to begin power delivery later this year as it works to finalize new long-term agreements.
Fermi Inc. (NASDAQ:FRMI) is a developer of private power campuses for AI-centric clients. It is involved in creating and operating an integrated power generation and computing infrastructure. Additionally, it also engages in the development and renting of grid-independent energy generation and high-performance computing campuses.
While we acknowledge the potential of FRMI to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than FRMI and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: 10 Cheap NYSE Stocks to Buy According to Analysts and 10 Cheap NASDAQ Stocks to Buy Right Now.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
